Timothy Enns

President and Chief Executive Officer

Timothy Enns is a eficient expert, that works in Nanovalent Pharmaceuticals on the position of President and Chief Executive Officer from 2016. Timothy gained professional experience in more than 11 positions at various companies. Timothy Enns went to the Stanford University Graduate School of Business and received education there from 2007 to 2007. Berkeley, California is the area, where this person was known to settle. The person's email address and number can be easily accessed through this website on demand.
Name variants:
Tim Enns, Timmy Enns
Last updated Jun 21, 2024

Contact Information

Last Update
Jul 5, 2022
Email
ti**@astx.com, te**@supergen.com
Location
Berkeley, CA
Company
Nanovalent Pharmaceuticals

Workplace

President and Chief Executive Officer

Work History

President and Chief Executive Officer

Exciting preclinical stage biotechnology company that has progressed three ADC targeted nano-particles to enter the clinic in 2019. We have completed our first external financing to engage G...
from Oct 2016

Biotechnology Executive

Consulting with private and public biotechnology companies on improving their strategic marketing, communications and investor outreach efforts.
Aug 2014 — Sep 2016

Chief Investor and Media Relations Officer

5980 Horton St SUITE 470, Emeryville, CA 94608
I was brought on to head external communications, IR strategy and help drive a successful initial public offering.
Jan 2014 — Aug 2014

Senior Vice President Corporate Communication and Marketing

4420 Rosewood Dr SUITE 200, Pleasanton, CA 94588
Was responsible for all global corporate communication and marketing. This included Investor Relations, Public Relations and the evaluation and positioning of corporate assets. Reporting to ...
Mar 1999 — Dec 2013

Senior Director Marketing and Special Projects

Responsible for all aspects of sales logistics, reimbursement strategy and execution for Doxil and Amphotec. Directed all off-label training. Achieved a 75% Medicare acceptance in 60 days fo...
Jan 1998 — Mar 1999

Co-Founder and Senior Vice President

A therapeutic cancer vaccine company. I was responsible for all commercial departments, negotiating the licensing rights and managing the IP portfolio. Three products advanced to Phase II cl...
Jan 1995 — Jan 1998

Director Technology and Product Development

A venture project for SenMed Medical Ventures. I was responsible for diligence on corporate projects and assets. Transferred academic technology to commercial GLP setting for further manufac...
Mar 1994 — Jan 1995

Project Director

I was brought on to help validate a new business concept. The concept was "just in time" IV cancer medication for outpatient clinics and offices. Created necessary marketing and business sof...
Jun 1991 — Mar 1994

Oncology Territory Manager

Recruited to lanuch the rebranded company and first commercial product Didronel for hypercalcemia of malignancy
Jan 1990 — Apr 1991

Clinical Oncology Associate

Oncology Sales Specialist with oversight of SWOG & NSABP clinical cancer study groups.
Sep 1985 — Dec 1989

Sales Represenative

Launched Xanax, Halcion & Cortaid. Managed and grew Motrin, Cleocin & Orinase franchises.
May 1982 — Sep 1985

Occupations

Executive
Chief Executive Officer
Chairperson
Scientist
Biotechnology Professional
Bachelor of Liberal Arts
Investor
Corporate Executive
Chief Executive
Biologist
Biological Scientist

Skills

Oncology
Drug Development
Pharmaceutical Industry
Biotechnology
Biopharmaceuticals
Drug Discovery
Lifesciences
Cancer
Hematology
Infectious Diseases
Technology Transfer
Commercialization
Market Access
Regulatory Affairs
Corporate Communications
Clinical Trials
Pharmaceutical Sales
Vaccines
Clinical Research
Public Relations
Fda
Immunology
Gcp
Medical Writing
Regulatory Submissions
Sop
Molecular Biology
Life Sciences
Investor Relations
Management
Strategy
Start Ups
Strategic Planning
Marketing
Product Launch
Business Strategy
Login